ClinicalTrials.gg
CompletedNCT07344857Updated Jan 22, 2026

Prenatal Pilates and Postpartum Ligamentous Laxity

An observational study in Laxity of Ligament, Pregnancy and Pilates Exercise, sponsored by Ankara Medipol University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 20 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-01-22.

Sponsored by Ankara Medipol University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
42
Ages
20 Years to 35 Years
Sex
Female
01

Study summary

Pregnancy induces hormonal and biomechanical adaptations that increase ligamentous laxity, which may persist into the postpartum period and contribute to joint instability, pain, and functional limitations. Although prenatal Pilates has been shown to prevent the progression of ligamentous laxity during pregnancy, its effects on postpartum musculoskeletal recovery remain unclear. This longitudinal follow-up of a randomized controlled trial evaluated ligamentous recovery at 6 weeks postpartum in women who participated in a structured prenatal Pilates program continued until childbirth, compared with women receiving standard prenatal care. Postpartum ligamentous laxity, generalized joint hypermobility, and activity limitations related to pelvic girdle pain were assessed using objective and clinical measures. The study aimed to determine whether prenatal Pilates facilitates early postpartum ligamentous recovery and supports functional outcomes during the early postpartum period.

02

Conditions studied

  • Laxity of Ligament
  • Pregnancy
  • Pilates Exercise

Browse trials for

03

In context

Joint Instability

115 studies on the registry are indexed under Joint Instability; 21 are open to participants now.

This study's enrollment of 42 is below the median of 60 across 54 observational studies indexed under Joint Instability.

Browse Joint Instability studies →

Lead sponsor

Ankara Medipol University is the lead sponsor of 56 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consisted of postpartum women aged 18-35 years who were 6th week after delivery and who voluntarily agreed to participate in the study. Women with known cardiovascular or pulmonary diseases, and those who had participated in structured physical activity programs prior to enrollment were excluded. These criteria were applied to ensure a homogeneous sample and to minimize potential confounding factors related to pre-existing health conditions or prior exercise exposure.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 18-35 years
  • In the 6th week of post-partum
  • Voluntary participation in the study

Exclusion criteria

Exclusion Criteria:

  • Cardiovascular or pulmonary diseases
  • Prior participation in structured physical activity programs
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
42 participants (actual)
Patient registry
No

Groups and cohorts

  • Pilates Group

    Participants in the Pilates group attended supervised 60-minute sessions twice weekly for eight weeks, led by a certified physiotherapist trained by the Australian Institute of Pilates and Physiotherapy.

  • Control Group

    The control group received standard prenatal care and ergonomic advice, and did not participate in any exercise training.

06

What researchers measure

Primary outcomes

  1. Ligament laxity

    The anterior tibial translation of the knee will be considered as representative of the anterior laxity of the knee of women measured with an arthrometer ® (bilateral examination repeated 3 times on each knee).The degree of laxity will be evaluated thanks to the international classification IKDC.

    Time frame: 10 minutes

Secondary outcomes

  1. Generalized joint hypermobility

    Generalized joint hypermobility (GJH) was assessed using the Beighton scoring system, which consists of five bilateral and unilateral maneuvers. Each positive test scored one point, with a maximum score of 9. A score of ≥5 indicated GJH.

    Time frame: 2 minutes

  2. Physical activity level

    Participants' physical activity was monitored using the Omron HJ-321-E pedometer (Omron Healthcare, Japan), which detects vertical oscillations and stores up to seven days of data.

    Time frame: 7 days

07

Study locations

1 site
  • Ankara Medipol University
    Ankara, Altındağ 06050, Turkey (Türkiye)
08

References and documents

Publications

  • Bulguroglu HI, Bulguroglu M, Degirmenci B, Suicmez S, Aslan CG, Develik SZ, Atalay Guzel N. Effect of continued prenatal Pilates until childbirth on postpartum ligamentous recovery: a longitudinal follow-up of a randomized controlled trial. BMC Pregnancy Childbirth. 2026 May 1;26(1):663. doi: 10.1186/s12884-026-09183-1. PubMed 42067815 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2025 to primary completion in Jan 2026, 1 month.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 8, 2026
First posted
Jan 15, 2026
StartActual
Nov 20, 2025
Primary completionActual
Jan 15, 2026
CompletionActual
Jan 15, 2026
Last update
Jan 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07344857
Lead sponsor
Ankara Medipol University
Responsible party
Selcan Suicmez (Research Asst., Ankara Medipol University) — Principal investigator
First posted
Jan 15, 2026
Start date
Nov 20, 2025
Primary completion
Jan 15, 2026
Completion
Jan 15, 2026
Last update
Jan 22, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion